In last trading session, GeneDx Holdings Corp (NASDAQ:WGS) saw 0.67 million shares changing hands with its beta currently measuring 2.07. Company’s recent per share price level of $77.87 trading at -$2.55 or -3.17% at ring of the bell on the day assigns it a market valuation of $2.22B. That closing price of WGS’s stock is at a discount of -51.21% from its 52-week high price of $117.75 and is indicating a premium of 67.48% from its 52-week low price of $25.32. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.73 million shares which gives us an average trading volume of 1.17 million if we extend that period to 3-months.
For GeneDx Holdings Corp (WGS), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.29. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
GeneDx Holdings Corp (NASDAQ:WGS) trade information
GeneDx Holdings Corp’s shares saw a change of 142.89% in year-to-date performance and have moved -5.68% in past 5-day. GeneDx Holdings Corp (NASDAQ:WGS) showed a performance of 21.60% in past 30-days. Number of shares sold short was 3.75 million shares which calculate 4.35 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 39.5 to the stock, which implies a fall of -97.14% to its current value. Analysts have been projecting 21 as a low price target for the stock while placing it at a high target of 70. It follows that stock’s current price would jump 73.03% in reaching the projected high whereas dropping to the targeted low would mean a gain of 73.03% for stock’s current value.
GeneDx Holdings Corp (WGS) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 96.65% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 327.64% while estimates for its earnings growth in next 5 years are of 120.66%.
GeneDx Holdings Corp (NASDAQ:WGS)’s Major holders
Insiders are in possession of 12.56% of company’s total shares while institution are holding 102.71 percent of that, with stock having share float percentage of 117.47%. Investors also watch the number of corporate investors in a company very closely, which is 102.71% institutions for GeneDx Holdings Corp that are currently holding shares of the company. CASDIN CAPITAL, LLC is the top institutional holder at WGS for having 3.53 million shares of worth $92.18 million. And as of 2024-06-30, it was holding 13.2482 of the company’s outstanding shares.
The second largest institutional holder is CORVEX MANAGEMENT LP, which was holding about 2.47 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.2937 of outstanding shares, having a total worth of $64.66 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and ALGER FUNDS-Alger Small Cap Focus Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 527.75 shares of worth $41.1 million or 1.85% of the total outstanding shares. The later fund manager was in possession of 369.03 shares on Apr 30, 2025 , making its stake of worth around $28.74 million in the company or a holder of 1.29% of company’s stock.
